With dermatologic side effects being fairly prevalent following vaccination against COVID‐
19, and the multitude of studies aiming to report and analyze these adverse events, the need …

Monkeypox is a zoonotic disease, endemic in central and west African regions, and has re‐
emerged, currently causing an outbreak as of May 2022. In this systematic review, we aimed …

To determine the safety and efficacy profile of teenager COVID‐19 vaccination. In this
retrospective cohort study, contact numbers of parents of teenagers under 18 years of age …

While mucocutaneous manifestations of COVID-19 have been frequently reported and
added to our knowledge every day during the pandemic, another issue is the COVID-related …

The mucocutaneous manifestations of Corona Virus Disease 2019 (COVID‐19) logically
may reflect systemic visceral involvements. These findings are visible and easy to approach …

Objectives Earlier diagnosis and the best management of virus‐related, drug‐related or
mixed severe potentially life‐threatening mucocutaneous reactions of COVID‐19 patients …

Background Tissue fillers are among the most popular cosmetic procedures performed and
notably, cases of filler reactions after COVID‐19 vaccination have been reported. Objective …

Cases of filler reactions after COVID‐19 vaccination have been reported. Here, we present
the first case of delayed‐type reaction (DTR) to non‐hyaluronic acid Polycaprolactone …

This narrative review article was conducted to lay out a summarized but exhaustive review of
current literature over mucocutaneous manifestations in 4 dimensions of SARS‐CoV‐2 …

Background Rituximab is a FDA-approved monoclonal antibody for adults with moderate to
severe potentially life-threatening pemphigus vulgaris. Recent studies have focused on …